Background: Within a few years of diagnosis, patients with Type 2 Diabetes Mellitus (T2DM) develop hypertension. It has been hypothesized that both are part of metabolic syndrome. However, studies on diabetic patients have been undertaken while they are on treatment for diabetes. Thus, the results of these studies and inference drawn thereon may not be due to the diabetic process per se but may also be due to the medications.
Methods: A comprehensive literature search was carried out on PubMed, EMBASE and Cochrane databases and articles published between January 1970 to June 2015 were reviewed.
Results: Sulfonylureas due to their action on SUR1 in pituitary gland may release growth hormone and anti-diuretic hormone; action on SUR2B acting upon smooth muscle may interfere with vasodilatation, thereby causing hypertension.
Conclusions: Sulfonylureas may cause hypertension by their extra-pancreatic effects, further studies are needed to validate this hypothesis.
Keywords: Hypertension, type 2 diabetes, sulfonylureas, sulfonylurea, adenosine triphosphate, potassium channels.
Modeling Loss of Microvascular Wall Homeostasis during Glycocalyx Deterioration and Hypertension that Impacts Plasma Filtration and Solute Exchange
Current Neurovascular Research Statins in Diabetes Mellitus
Current Pharmaceutical Design Metformin and Pregnancy Outcomes: Evidence Gaps and Unanswered Questions
Current Clinical Pharmacology Is There An Association Between Vitamin D and Hypertension?
Recent Patents on Cardiovascular Drug Discovery (Discontinued) A Review of the Evidence for a Neuroendocrine Link Between Stress, Depression and Diabetes Mellitus
Current Diabetes Reviews Perioperative Considerations in Diabetic Patients
Current Diabetes Reviews A Review of Natural and Synthetic Antioxidants Important for Health and Longevity
Current Medicinal Chemistry Primary and Secondary Hypertriglyceridaemia
Current Drug Targets Metabolic Control of Type 2 Diabetes by Targeting the GLUT4 Glucose Transporter: Intervention Approaches
Current Pharmaceutical Design Overview of Current and Upcoming Strategies Implied for the Therapy of Type 2 Diabetes Mellitus
Current Diabetes Reviews Abnormal Peri-Organ or Intra-organ Fat (APIFat) Deposition: An Underestimated Predictor of Vascular Risk?
Current Vascular Pharmacology Selective Divalent Copper Chelation for the Treatment of Diabetes Mellitus
Current Medicinal Chemistry Conventional and Alternative Treatment Options for Allergic Rhinitis
Current Respiratory Medicine Reviews Roles of Insulin Resistance, Endothelial Dysfunction and Lifestyle Changes in the Development of Cardiovascular Disease in Diabetic Patients
Current Drug Targets Molecular Action of Metformin in Hepatocytes: An Updated Insight
Current Diabetes Reviews Model for Gestational Diabetes on Web Based Parameters
Recent Patents on Engineering Weight Loss in Obesity and Metabolic Syndrome
Current Hypertension Reviews Preventing Type 2 Diabetes in High Risk Patients: An Overview of Lifestyle and Pharmacological Measures
Current Drug Targets Immunosuppression and Post-transplant Hyperglycemia
Current Diabetes Reviews Relationship Between Hypertension and Atherosclerosis: From a Viewpoint of the Most Potent Vasoconstrictor Human Urotensin II
Current Hypertension Reviews